Cargando…
The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
Background: Many clinical factors can contribute to the efficacy of medical therapy in Inflammatory Bowel Disease (IBD). We assessed their effects on the efficacy of vedolizumab therapy in a cohort of patients with IBD. Methods: We conducted a retrospective study on patients between 18 and 80 years...
Autores principales: | Abraham, Bincy P., Fan, Christopher, Thurston, Theresa, Moskow, Joshua, Malaty, Hoda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674273/ https://www.ncbi.nlm.nih.gov/pubmed/38004241 http://dx.doi.org/10.3390/nu15224847 |
Ejemplares similares
-
The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period
por: Malaty, Hoda M, et al.
Publicado: (2013) -
Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab
por: Krupka, Niklas, et al.
Publicado: (2014) -
Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020) -
The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
por: Choi, Myeong Geun, et al.
Publicado: (2022) -
Long‐term safety of vedolizumab for inflammatory bowel disease
por: Loftus, Edward V., et al.
Publicado: (2020)